Clinical trials

This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (within 100 days of diagnosis). Participants will…

Ages

8 Years - 45 Years

Sexes

All

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab…

Investigator

Michael J Haller

Ages

1 Year - 25 Years

Sexes

All

This is a Phase 2b, investigator* and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D).

Investigator

Laura Jacobsen

Ages

5 Years - 40 Years

Sexes

All